
NightHawk Biosciences, Inc.
AMEX:NHWK
0.38 (USD) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | NightHawk Biosciences, Inc. |
Symbool | NHWK |
Munteenheid | USD |
Prijs | 0.442 |
Beurswaarde | 11,517,767 |
Dividendpercentage | 0% |
52-weken bereik | 0.36 - 1.52 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jeffrey Alan Wolf J.D. |
Website | https://www.nighthawkbio.com |
An error occurred while fetching data.
Over NightHawk Biosciences, Inc.
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)